MEROPEN

Each 1ml contains :

Composition:

Meropenem ......................................................................1 g

Meropenem ..................................................................500 mg

Indications :

Intra-abdominal infections, nosocominal pneumonia, septicaemia, cystic fibrosis, meningitis, febrile neutropenia.

   Description:

The bactericidal activity of meropenem results from the inhibition of cell wall synthesis. Meropenem readily penetrates the cell wall of most Gram-positive and Gram-negative bacteria to reach penicillin-binding- protein (PBP) targets. Its strongest affinities are toward PBPs 2, 3 and 4 of Escherichia coli and Pseudomonas aeruginosa; and PBPs 1, 2 and 4 of Staphylococcus aureus.

Dosage : Intra-abdominal infections; nosocominal pneumonia; septicaemia:  Adults: 500mg-1g hrly depending on the severity and type. IV infusion, over approx. 15 to 30 minutes or as an intravenous bolus injection (5 to 20 mL) over approximately 3-5minutes.  Child: (3 months to 12 yrs): IV 10 to 40mg/kg 8hrly, or as reqd.  Cystic fibrosis; meningitis: Adults: 2g 8 hrly.  Febrile neutropenia: 1g 8 hrly.

Note : This product information is intended only for residents of the India. Taj Pharmaceuticals Limited,  medicines help to treat and prevent a range of conditions—from the most common to the most challenging—for people around the world.

Information for Health Care Professionals

*** Please consult local Prescribing Information for any product before use. This website is an international information resource for healthcare professionals with an interest in disease management. This website is not intended to replace the advice of a qualified healthcare professional. Above brand is a trademark of the Taj group of companies (Taj Pharmaceuticals Limited).

Select Language English Russian French German Italian Japanese Korean Portuguese Spanish Greek Dutch Hindi

              
 Print page   Send by mail